Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes.
暂无分享,去创建一个
M. Rubin | S. Silverberg | D. McMahon | Hong-feng Jiang | L. Bandeira | S. Agarwal | K. Nishiyama | E. Dworakowski | J. Furst | Wen-wei Fan | Hongfeng Jiang | Sanchita Agarwal
[1] M. Lorentzon,et al. A High Amount of Local Adipose Tissue Is Associated With High Cortical Porosity and Low Bone Material Strength in Older Women , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] P. Vestergaard,et al. Bone Structure and Predictors of Fracture in Type 1 and Type 2 Diabetes. , 2016, The Journal of clinical endocrinology and metabolism.
[3] M. Frost,et al. Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease. , 2015, European journal of endocrinology.
[4] S. Saydah,et al. Diabetes and fracture risk in older U.S. adults. , 2016, Bone.
[5] M. Bouxsein,et al. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties. , 2016, Bone.
[6] C. Cooper,et al. Bone Microarchitecture in Men and Women with Diabetes: The Importance of Cortical Porosity , 2015, Calcified Tissue International.
[7] D. Vashishth,et al. A direct role of collagen glycation in bone fracture. , 2015, Journal of the mechanical behavior of biomedical materials.
[8] Sarah L Manske,et al. Human trabecular bone microarchitecture can be assessed independently of density with second generation HR-pQCT. , 2015, Bone.
[9] Joseph M. Wallace,et al. True Gold or Pyrite: A Review of Reference Point Indentation for Assessing Bone Mechanical Properties In Vivo , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] M. Saito,et al. Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease , 2015, Calcified Tissue International.
[11] S. Papapoulos,et al. Bone material strength as measured by microindentation in vivo is decreased in patients with fragility fractures independently of bone mineral density. , 2015, The Journal of clinical endocrinology and metabolism.
[12] H. Choi,et al. Trabecular bone score as an indicator for skeletal deterioration in diabetes. , 2015, The Journal of clinical endocrinology and metabolism.
[13] C. Cooper,et al. Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study , 2015, Osteoporosis International.
[14] M. Bouxsein,et al. Defects in cortical microarchitecture among African-American women with type 2 diabetes , 2015, Osteoporosis International.
[15] D. Cibula,et al. Bone quality assessment in type 2 diabetes mellitus , 2014, Osteoporosis International.
[16] S. Khosla,et al. In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[17] P. Vestergaard,et al. Biochemical markers of bone turnover in diabetes patients—a meta-analysis, and a methodological study on the effects of glucose on bone markers , 2014, Osteoporosis International.
[18] Noriko Yoshimura,et al. A Meta‐Analysis of the Association of Fracture Risk and Body Mass Index in Women , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] Daniel C Bridges,et al. Applications of a New Handheld Reference Point Indentation Instrument Measuring Bone Material Strength. , 2013, Journal of medical devices.
[20] M. Huijberts,et al. Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies. , 2013, The Journal of clinical endocrinology and metabolism.
[21] S. Ponzer,et al. Health related quality of life, reoperation rate and function in patients with diabetes mellitus and hip fracture--a 2 year follow-up study. , 2013, Injury.
[22] Thomas Baum,et al. Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] W. Leslie,et al. TBS (trabecular bone score) and diabetes-related fracture risk. , 2013, The Journal of clinical endocrinology and metabolism.
[24] J. Kanis,et al. Type 2 diabetes and bone , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] Diabetes and health outcomes among older Taiwanese with hip fracture. , 2012, Rejuvenation research.
[26] Liwei Zhang,et al. Metabolic memory: mechanisms and implications for diabetic retinopathy. , 2012, Diabetes research and clinical practice.
[27] Daniel C Bridges,et al. A new device for performing reference point indentation without a reference probe. , 2012, The Review of scientific instruments.
[28] Lili Ma,et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies , 2012, European Journal of Epidemiology.
[29] L. Giangregorio,et al. Association of larger holes in the trabecular bone at the distal radius in postmenopausal women with type 2 diabetes mellitus compared to controls , 2012, Arthritis care & research.
[30] S. Cremers,et al. Bone structure and turnover in type 2 diabetes mellitus , 2012, Osteoporosis International.
[31] J. Bilezikian,et al. A randomized, parallel group, double‐blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long‐term glycaemic control and bone mineral density after 80 weeks of treatment in drug‐naïve type 2 diabetes mellitus patients , 2011, Diabetes, obesity & metabolism.
[32] R. Nagatomi,et al. Skin advanced glycation end-product accumulation is negatively associated with calcaneal osteo-sono assessment index among non-diabetic adult Japanese men , 2011, Osteoporosis International.
[33] Heather M. Macdonald,et al. Age‐related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: A population‐based HR‐pQCT study , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] Allison E. Williams,et al. Arthroplasty in veterans: analysis of cartilage, bone, serum, and synovial fluid reveals differences and similarities in osteoarthritis with and without comorbid diabetes. , 2011, Journal of rehabilitation research and development.
[35] S. Majumdar,et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. , 2010, Journal of Clinical Endocrinology and Metabolism.
[36] Reindert Graaff,et al. Skin color independent assessment of aging using skin autofluorescence. , 2010, Optics express.
[37] Jian-Min Yuan,et al. Diabetes and Risk of Hip Fracture in the Singapore Chinese Health Study , 2010, Diabetes Care.
[38] Daniel C Bridges,et al. Microindentation for In Vivo Measurement of Bone Tissue Mechanical Properties in Humans , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] Morton B. Brown,et al. The bone diagnostic instrument II: indentation distance increase. , 2008, The Review of scientific instruments.
[40] Walter C Willett,et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. , 2007, American journal of epidemiology.
[41] P. Vestergaard,et al. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis , 2007, Osteoporosis International.
[42] Karen C Johnson,et al. Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. , 2006, The Journal of clinical endocrinology and metabolism.
[43] M. Bouxsein,et al. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. , 2005, The Journal of clinical endocrinology and metabolism.
[44] P. Odetti,et al. Advanced Glycation End Products and Bone Loss during Aging , 2005, Annals of the New York Academy of Sciences.
[45] Vashishith. EFFECTS OF NON-ENZYMATIC GLYCATION ON CANCELLOUS BONE FRAGILITY , 2005 .
[46] R. Gans,et al. Simple non-invasive assessment of advanced glycation endproduct accumulation , 2004, Diabetologia.
[47] S. Etcheverry,et al. Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix. , 2004, The international journal of biochemistry & cell biology.
[48] J. Clausen,et al. Factors in human serum interfere with the measurement of advanced glycation endproducts. , 1998, Cellular and molecular biology.
[49] Paul J Thornalley,et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. , 1998, The Journal of clinical investigation.
[50] V. Monnier,et al. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. , 1989, The Journal of biological chemistry.
[51] T. Fitzpatrick. The validity and practicality of sun-reactive skin types I through VI. , 1988, Archives of dermatology.